Nu Skin Shares Drop Sharply on China Woes, FX Hit

In looking at the long term dividend history, on average over the past five years, Nu Skin Enterprises, Inc. has paid out $0.894 to shareholders annually. The company’s shares opened today at $39.76, close to its 52-week low of $36.98. The total amount of the transaction was worth $861,750, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.

Nu Skin Enterprises (NYSE: NUS) updated its revenue guidance for the third quarter of 2015 in advance of this week’s global sales leader convention.

Nu Skin Enterprises (NYSE:NUS) had its price objective lowered by Pivotal Research from $75.00 to $50.00 in a report released on Wednesday morning, Marketbeat reports.

Sterne Agee CRT analyst April Scee remains Neutral-rated on Nu Skin and raised more questions than other analysts about the company’s problems. TheStreet raised Nu Skin Enterprises from a hold rating to a buy rating in a research note on Tuesday, September 15th. 1 analysts have added the shares in their list of strong buys. Sales in the year-ago period stopped at $639 million, which means that Nu Skin’s revenues will plunge approximately 10% lower year over year. Institutional Investors own 79.1% of Company shares.

Brokerage firm JP Morgan Maintains its rating on Nu Skin Enterprises(NYSE:NUS).

Oracle Corporation (NYSE:ORCL) was trading with a volume of 1.29 million shares versus the average volume of the stock 18.72 million shares. (NYSE:NUS) stock plunged over 24% today after the company revised down third-quarter fiscal year 2015 (3QFY15) revenue guidance, as disclosed in a press-release after markets closed yesterday. Nu Skin’s current market cap stands at $2.00 billion. The business’s revenue was down 13.8% compared to the same quarter a year ago. (NYSE:NUS). In the latest research report, Canaccord Genuity raises the target price from $47 per share to $48 per share on the shares. Stockholders of record on Friday, August 28th were issued a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a yield of 3.01%. The ex-dividend date was Wednesday, August 26th. The highest estimate sees the stock going to $60 while the lowest has a $44 target. The Business develops and distributes anti-aging nutritional and personal care products supplements under its Nu Skin and Pharmanex brands. The Business has Nu Skin personal care products and Pharmanex nutritional supplements under its age LOC anti-aging brand. Products in this class include its ageLOC Galvanic Spa System, its ageLOC Galvanic Body Spa, ageLOC Galvanic Spa Body Shaping Gel and ageLOC Dermatic Effects Body Contouring Lotion and its ageLOC Transformation anti-aging skin care system. LifePak, its line of micronutrient supplements. Other anti-aging nutritional supplements contain its ageLOC R2, which is created to renew and recharge the body.